In The Age Of Ozempic, Have We Lost The Ethical Plot?
The current hype about weight loss drugs is inescapable, and media coverage is worryingly - and consistently - uncritical. I recently came across this article on the ABC news website: ‘Doctors weigh societal costs of using obesity drugs to treat obesity crisis.’ But...
Fast Track Trial Outcomes: Did Strict Dieting Really Improve Eating Disorder Symptoms?
Welcome back to my dissection of the Fast Track Trial paper 'Symptoms of Depression, Eating Disorders and Depression in Adolescents With Obesity'. This will make much more sense if you read Part 1 first. A heads up - this post contains multiple references to fat...
Fast Track Trial Outcomes Prove There’s No Safe Way To Starve Teenagers
Today I’m wading through the Fast Trackers' JAMA publication, Symptoms of Depression, Eating Disorders and Binge Eating in Adolescents With Obesity. There’s so much going on here that it's going to be a two-parter. This will make more sense if you’ve already read Part...
Fast Track Trial Update: 141 Australian Teenagers Have Now Been Starved in The Name of ‘Research’
A triumphant headline recently popped into my inbox - ‘How Intermittent Fasting Could Transform Adolescent Obesity.’ Yes folks, the controversial ‘Fast Track To Health’ Trial results have been published in JAMA. I’ve written at length about this previously, but...
Risky Business Part 2: SELECT’s Dirty Little Secret
Welcome to Part 2 of Novo Nordisk's masterful marketing push to turn their weight loss drugs into cardiovascular life savers. You can read Part 1 here. We'll start with an overview of the clinical trial at the centre of Novo's PR stunt, the 'Semaglutide Effects on...
Risky Business: How Novo Nordisk’s Marketing Machine Turned Their Weight Loss Drugs Into Cardiovascular Life Savers
The weight loss industry has always been a bullshit PR machine but Novo Nordisk has created a gargantuan geyser of misinformation. In August 2023 they issued a strategic press release claiming that their weight loss drug Wegovy reduced ‘major cardiovascular events...
